Table 1.
Study characteristics | Number (n = 46) | Percentage |
Study design | ||
Randomised controlled trial | 30 | 65.2 |
Before and after (no control) | 7 | 15.2 |
Controlled before & after | 6 | 13.0 |
Controlled clinical trial | 3 | 6.5 |
Year published | ||
Pre-2000 | 7 | 15.2 |
2000 and later | 39 | 84.8 |
Settings | ||
Primary Care | 35 | 76.1 |
Pharmacy | 6 | 13.0 |
Community | 1 | 2.2 |
Community based care | 2 | 4.3 |
Managed Care Organisation | 2 | 4.3 |
Intervention area | ||
Urban | 30 | 65.2 |
Urban and rural | 8 | 17.4 |
Rural | 5 | 10.9 |
Remote | 1 | 2.2 |
Not clear | 2 | 4.3 |
Country | ||
USA | 23 | 50.0 |
UK | 12 | 26.1 |
Netherlands | 4 | 8.7 |
Australia | 2 | 4.3 |
Canada | 2 | 4.3 |
Other | 3 | 6.5 |
Chronic Disease | ||
Cardiovascular conditions | 12 | 26.1 |
Diabetes & related conditions | 12 | 26.1 |
Not mentioned | 10 | 21.7 |
2 or more chronic conditions | 6 | 13.0 |
Musculo-skeletal conditions | 2 | 4.3 |
Mental conditions | 3 | 6.5 |
Respiratory conditions | 1 | 2.2 |